These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management. Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154 [TBL] [Abstract][Full Text] [Related]
5. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374 [TBL] [Abstract][Full Text] [Related]
6. The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma. Grépin R; Guyot M; Giuliano S; Boncompagni M; Ambrosetti D; Chamorey E; Scoazec JY; Negrier S; Simonnet H; Pagès G Cancer Res; 2014 Feb; 74(3):873-83. PubMed ID: 24335961 [TBL] [Abstract][Full Text] [Related]
8. Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma. Wondergem B; Zhang Z; Huang D; Ong CK; Koeman J; Hof DV; Petillo D; Ooi A; Anema J; Lane B; Kahnoski RJ; Furge KA; Teh BT Cancer Res; 2012 Sep; 72(17):4361-71. PubMed ID: 22805307 [TBL] [Abstract][Full Text] [Related]
9. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch. Goka ET; Chaturvedi P; Lopez DTM; Lippman ME Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578 [TBL] [Abstract][Full Text] [Related]
10. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma]. Chang BD; Cao LS; Zhou HL Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866 [TBL] [Abstract][Full Text] [Related]
11. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells. Mangieri D; Nico B; Coluccia AM; Vacca A; Ponzoni M; Ribatti D Cancer Lett; 2009 May; 277(2):199-204. PubMed ID: 19150583 [TBL] [Abstract][Full Text] [Related]
12. The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma. García M; Palma MB; Verine J; Miriuka S; Inda AM; Errecalde AL; Desgrandchamps F; Carosella ED; Tronik-Le Roux D BMC Cancer; 2020 Jul; 20(1):624. PubMed ID: 32620162 [TBL] [Abstract][Full Text] [Related]
13. Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas. Liszka Ł; Pająk J; Gołka D Pathol Res Pract; 2014 Dec; 210(12):901-8. PubMed ID: 25155377 [TBL] [Abstract][Full Text] [Related]
14. The chick embryo chorioallantoic membrane as a model for tumor biology. Ribatti D Exp Cell Res; 2014 Nov; 328(2):314-24. PubMed ID: 24972385 [TBL] [Abstract][Full Text] [Related]
15. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma. Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121 [TBL] [Abstract][Full Text] [Related]
16. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome. Cuadros T; Trilla E; Sarró E; Vilà MR; Vilardell J; de Torres I; Salcedo M; López-Hellin J; Sánchez A; Ramón y Cajal S; Itarte E; Morote J; Meseguer A Cancer Res; 2014 Mar; 74(5):1416-28. PubMed ID: 24390735 [TBL] [Abstract][Full Text] [Related]
17. Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. Mertz KD; Demichelis F; Kim R; Schraml P; Storz M; Diener PA; Moch H; Rubin MA Hum Pathol; 2007 Oct; 38(10):1454-62. PubMed ID: 17889675 [TBL] [Abstract][Full Text] [Related]
18. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508 [TBL] [Abstract][Full Text] [Related]
19. Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Cao Y; Zhang ZL; Zhou M; Elson P; Rini B; Aydin H; Feenstra K; Tan MH; Berghuis B; Tabbey R; Resau JH; Zhou FJ; Teh BT; Qian CN Cancer; 2013 Jan; 119(2):313-24. PubMed ID: 22811049 [TBL] [Abstract][Full Text] [Related]
20. Identification of angiogenesis-related miRNAs in a population of patients with renal clear cell carcinoma. Li HC; Li JP; Wang ZM; Fu DL; Li ZL; Zhang D; Gan WM; Chong T Oncol Rep; 2014 Nov; 32(5):2061-9. PubMed ID: 25119741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]